The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination

BACKGROUND: Sphingosine-one phosphate receptor (S1PR) modulation inhibits S1PR1-mediated lymphocyte migration, lesion formation and positively-impacts on active multiple sclerosis (MS). These S1PR modulatory drugs have different: European Union use restrictions, pharmacokinetics, metabolic profiles...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, David, Forte, Eugenia, Pryce, Gareth, Kang, Angray S., James, Louisa K., Giovannoni, Gavin, Schmierer, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678390/
https://www.ncbi.nlm.nih.gov/pubmed/36470168
http://dx.doi.org/10.1016/j.msard.2022.104425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678390/
https://www.ncbi.nlm.nih.gov/pubmed/36470168
http://dx.doi.org/10.1016/j.msard.2022.104425

Ejemplares similares